Michael Eisenberg

Associate

Weil, Gotshal & Manges LLP

Current

Current

Cree Inc. Gertrude Neumark Rothschild v. Cree, Inc. Markman hearing in Gertrude Neumark Rothschild v. Cree, Inc. Prevailed on 14 of 18 claim terms in dispute.

Current

Yeda Research and Development Company Israel Bio-Engineering Project v. Amgen, Inc. Weil Gotshal obtained summary judgment in the trial court, eliminating a critical challenge to client Yeda’s ownership claims to the patent covering Amgen’s blockbuster biotech drug Enbrel®. On appeal, Weil Gotshal’s appellate team secured the Federal Circuit’s affirmance. more

George Washington University

J.D.

2001

Florida State University

1997

M.S.

Washington University

B.A.

1994